Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Lumentum (LITE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Lumentum — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Lumentum trades at $1,086.53 (market cap $100.64B). The key difference: Lumentum is far larger — about 21.4× Definium Therapeutics Inc. Common Shares's market cap, and Lumentum is more actively traded (3,383,346 versus 1,966,636). Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Lumentum for 4 Days on average.
| DFTX | LITE | |
|---|---|---|
Market Cap | $4.71B | $100.64B |
Volume | 1,966,636 | 3,383,346 |
Sector | Health | Technology |
52-Week High | $48.45 | $1.13K |
52-Week Low | $10.68 | $149.61 |
Typical Hold Time | 0 Days | 4 Days |
Enterprise Value | $3.67B | $99.58B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Lumentum
Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.
Read more on LITE →
